High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma.

Kenjiro Ogushi Takehiko YokoboriSumihito NobusawaTakahiro ShirakuraJunko HiratoBilguun Erkhem-OchirHaruka OkamiGendensuren DorjkhorlooAkira NishiMakoto SuzukiSayaka OtakeHiroshi SaekiKen Shirabe

Published in: Cancers (2023)

Our data suggest that assessing STMN1 expression in neuroblastoma could be a powerful indicator of prognosis and that STMN1 might be a promising therapeutic candidate against refractory neuroblastoma with and without MYCN amplification.

Keyphrases

poor prognosis
long non coding rna
electronic health record
machine learning
big data
human health
climate change
deep learning
nucleic acid